COVID-19 Impact on Global Neurologic Disorders Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 93 pages | ID: CF4A55BCC0EBEN
QYResearch

Abstracts

This report focuses on the global Neurologic Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neurologic Disorders Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Biogen Inc.
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson Services Inc.
• Novartis AG
• Pfizer Inc.
• ...

Market segment by Type, the product can be split into

• Central Nervous System (CNS)
• Peripheral Nervous System (PNS)

Market segment by Application, split into

• Paralysis
• Muscle Weakness
• Poor Coordination
• Loss of Sensation
• Seizures
• Confusion
• Pain and Altered Levels of Consciousness

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Neurologic Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Neurologic Disorders Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Neurologic Disorders Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neurologic Disorders Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Central Nervous System (CNS)
  1.4.3 Peripheral Nervous System (PNS)
1.5 Market by Application
  1.5.1 Global Neurologic Disorders Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Paralysis
  1.5.3 Muscle Weakness
  1.5.4 Poor Coordination
  1.5.5 Loss of Sensation
  1.5.6 Seizures
  1.5.7 Confusion
  1.5.8 Pain and Altered Levels of Consciousness
1.6 Coronavirus Disease 2019 (Covid-19): Neurologic Disorders Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Neurologic Disorders Therapeutics Industry
    1.6.1.1 Neurologic Disorders Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Neurologic Disorders Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Neurologic Disorders Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Neurologic Disorders Therapeutics Market Perspective (2015-2026)
2.2 Neurologic Disorders Therapeutics Growth Trends by Regions
  2.2.1 Neurologic Disorders Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Neurologic Disorders Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Neurologic Disorders Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Neurologic Disorders Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Neurologic Disorders Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Neurologic Disorders Therapeutics Players by Market Size
  3.1.1 Global Top Neurologic Disorders Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Neurologic Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neurologic Disorders Therapeutics Market Concentration Ratio
  3.2.1 Global Neurologic Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Neurologic Disorders Therapeutics Revenue in 2019
3.3 Neurologic Disorders Therapeutics Key Players Head office and Area Served
3.4 Key Players Neurologic Disorders Therapeutics Product Solution and Service
3.5 Date of Enter into Neurologic Disorders Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Neurologic Disorders Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Neurologic Disorders Therapeutics Forecasted Market Size by Type (2021-2026)

5 NEUROLOGIC DISORDERS THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Neurologic Disorders Therapeutics Market Size by Application (2015-2020)
5.2 Global Neurologic Disorders Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Neurologic Disorders Therapeutics Market Size (2015-2020)
6.2 Neurologic Disorders Therapeutics Key Players in North America (2019-2020)
6.3 North America Neurologic Disorders Therapeutics Market Size by Type (2015-2020)
6.4 North America Neurologic Disorders Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Neurologic Disorders Therapeutics Market Size (2015-2020)
7.2 Neurologic Disorders Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Neurologic Disorders Therapeutics Market Size by Type (2015-2020)
7.4 Europe Neurologic Disorders Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Neurologic Disorders Therapeutics Market Size (2015-2020)
8.2 Neurologic Disorders Therapeutics Key Players in China (2019-2020)
8.3 China Neurologic Disorders Therapeutics Market Size by Type (2015-2020)
8.4 China Neurologic Disorders Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Neurologic Disorders Therapeutics Market Size (2015-2020)
9.2 Neurologic Disorders Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Neurologic Disorders Therapeutics Market Size by Type (2015-2020)
9.4 Japan Neurologic Disorders Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Neurologic Disorders Therapeutics Market Size (2015-2020)
10.2 Neurologic Disorders Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neurologic Disorders Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Neurologic Disorders Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Neurologic Disorders Therapeutics Market Size (2015-2020)
11.2 Neurologic Disorders Therapeutics Key Players in India (2019-2020)
11.3 India Neurologic Disorders Therapeutics Market Size by Type (2015-2020)
11.4 India Neurologic Disorders Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Neurologic Disorders Therapeutics Market Size (2015-2020)
12.2 Neurologic Disorders Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Neurologic Disorders Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Neurologic Disorders Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Biogen Inc.
  13.1.1 Biogen Inc. Company Details
  13.1.2 Biogen Inc. Business Overview and Its Total Revenue
  13.1.3 Biogen Inc. Neurologic Disorders Therapeutics Introduction
  13.1.4 Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business (2015-2020))
  13.1.5 Biogen Inc. Recent Development
13.2 F. Hoffmann-La Roche Ltd.
  13.2.1 F. Hoffmann-La Roche Ltd. Company Details
  13.2.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
  13.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Introduction
  13.2.4 F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business (2015-2020)
  13.2.5 F. Hoffmann-La Roche Ltd. Recent Development
13.3 Johnson & Johnson Services Inc.
  13.3.1 Johnson & Johnson Services Inc. Company Details
  13.3.2 Johnson & Johnson Services Inc. Business Overview and Its Total Revenue
  13.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Introduction
  13.3.4 Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business (2015-2020)
  13.3.5 Johnson & Johnson Services Inc. Recent Development
13.4 Novartis AG
  13.4.1 Novartis AG Company Details
  13.4.2 Novartis AG Business Overview and Its Total Revenue
  13.4.3 Novartis AG Neurologic Disorders Therapeutics Introduction
  13.4.4 Novartis AG Revenue in Neurologic Disorders Therapeutics Business (2015-2020)
  13.4.5 Novartis AG Recent Development
13.5 Pfizer Inc.
  13.5.1 Pfizer Inc. Company Details
  13.5.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Introduction
  13.5.4 Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business (2015-2020)
  13.5.5 Pfizer Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Neurologic Disorders Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Neurologic Disorders Therapeutics Revenue
Table 3. Ranking of Global Top Neurologic Disorders Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Central Nervous System (CNS)
Table 6. Key Players of Peripheral Nervous System (PNS)
Table 7. COVID-19 Impact Global Market: (Four Neurologic Disorders Therapeutics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Neurologic Disorders Therapeutics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Neurologic Disorders Therapeutics Players to Combat Covid-19 Impact
Table 12. Global Neurologic Disorders Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Neurologic Disorders Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Neurologic Disorders Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Neurologic Disorders Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Neurologic Disorders Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Neurologic Disorders Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Neurologic Disorders Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Neurologic Disorders Therapeutics Players
Table 23. Global Neurologic Disorders Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Neurologic Disorders Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Neurologic Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurologic Disorders Therapeutics as of 2019)
Table 26. Global Neurologic Disorders Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Neurologic Disorders Therapeutics Product Solution and Service
Table 29. Date of Enter into Neurologic Disorders Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Neurologic Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Neurologic Disorders Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Neurologic Disorders Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Neurologic Disorders Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Neurologic Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Neurologic Disorders Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Neurologic Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Neurologic Disorders Therapeutics Market Share (2019-2020)
Table 39. North America Neurologic Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Neurologic Disorders Therapeutics Market Share by Type (2015-2020)
Table 41. North America Neurologic Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Neurologic Disorders Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Neurologic Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Neurologic Disorders Therapeutics Market Share (2019-2020)
Table 45. Europe Neurologic Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Neurologic Disorders Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Neurologic Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Neurologic Disorders Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players Neurologic Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Neurologic Disorders Therapeutics Market Share (2019-2020)
Table 51. China Neurologic Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China Neurologic Disorders Therapeutics Market Share by Type (2015-2020)
Table 53. China Neurologic Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China Neurologic Disorders Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players Neurologic Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Neurologic Disorders Therapeutics Market Share (2019-2020)
Table 57. Japan Neurologic Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Neurologic Disorders Therapeutics Market Share by Type (2015-2020)
Table 59. Japan Neurologic Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Neurologic Disorders Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Neurologic Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Neurologic Disorders Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia Neurologic Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Neurologic Disorders Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia Neurologic Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Neurologic Disorders Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players Neurologic Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Neurologic Disorders Therapeutics Market Share (2019-2020)
Table 69. India Neurologic Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India Neurologic Disorders Therapeutics Market Share by Type (2015-2020)
Table 71. India Neurologic Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India Neurologic Disorders Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Neurologic Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Neurologic Disorders Therapeutics Market Share (2019-2020)
Table 75. Central & South America Neurologic Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Neurologic Disorders Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America Neurologic Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Neurologic Disorders Therapeutics Market Share by Application (2015-2020)
Table 79. Biogen Inc. Company Details
Table 80. Biogen Inc. Business Overview
Table 81. Biogen Inc. Product
Table 82. Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business (2015-2020) (Million US$)
Table 83. Biogen Inc. Recent Development
Table 84. F. Hoffmann-La Roche Ltd. Company Details
Table 85. F. Hoffmann-La Roche Ltd. Business Overview
Table 86. F. Hoffmann-La Roche Ltd. Product
Table 87. F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business (2015-2020) (Million US$)
Table 88. F. Hoffmann-La Roche Ltd. Recent Development
Table 89. Johnson & Johnson Services Inc. Company Details
Table 90. Johnson & Johnson Services Inc. Business Overview
Table 91. Johnson & Johnson Services Inc. Product
Table 92. Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Services Inc. Recent Development
Table 94. Novartis AG Company Details
Table 95. Novartis AG Business Overview
Table 96. Novartis AG Product
Table 97. Novartis AG Revenue in Neurologic Disorders Therapeutics Business (2015-2020) (Million US$)
Table 98. Novartis AG Recent Development
Table 99. Pfizer Inc. Company Details
Table 100. Pfizer Inc. Business Overview
Table 101. Pfizer Inc. Product
Table 102. Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business (2015-2020) (Million US$)
Table 103. Pfizer Inc. Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Neurologic Disorders Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Central Nervous System (CNS) Features
Figure 3. Peripheral Nervous System (PNS) Features
Figure 4. Global Neurologic Disorders Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Paralysis Case Studies
Figure 6. Muscle Weakness Case Studies
Figure 7. Poor Coordination Case Studies
Figure 8. Loss of Sensation Case Studies
Figure 9. Seizures Case Studies
Figure 10. Confusion Case Studies
Figure 11. Pain and Altered Levels of Consciousness Case Studies
Figure 12. Neurologic Disorders Therapeutics Report Years Considered
Figure 13. Global Neurologic Disorders Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Neurologic Disorders Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Neurologic Disorders Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Neurologic Disorders Therapeutics Market Share by Players in 2019
Figure 18. Global Top Neurologic Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurologic Disorders Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Neurologic Disorders Therapeutics Revenue in 2019
Figure 20. North America Neurologic Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Neurologic Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Neurologic Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Neurologic Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Neurologic Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Neurologic Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Neurologic Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Biogen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Biogen Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2015-2020)
Figure 29. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2015-2020)
Figure 31. Johnson & Johnson Services Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Johnson & Johnson Services Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2015-2020)
Figure 33. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis AG Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2015-2020)
Figure 35. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Pfizer Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed